ArQule-500x300

ArQule is a bio-pharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases.

biopharmaceuticals
Public (NYSE:ARQL)
Visit Website
Additional Portfolio Companies
Adicet Bio
ArQule
BioBlast Pharma
Cathworks
cCAM Biotherapeutics
CheckCap
Eloxx Pharmaceuticals
Enlivex Therapeutics
Entera Bio
Eyevensys
EyeYon
ForSight Vision6 (“V6”)
Hairstetics
Headsense
Horama
Keros Therapeutics
Kite Pharma
LogicBio Therapeutics
Metabomed
NovellusDX
Novus Therapeutics
Ocon Medical
PACT Pharma
Pi Therapeutics
Protalix
Raziel Therapeutics
ReWalk
VBI Vaccines
Step Pharma
StimatixGI
Sweetch
TargEDys
UroGen
V-Wave
November 22, 2017